#REGENDO was named an #AIS26 runner-up for REGENDO-T, which uses a patient’s own cells to create functional thyroid follicles. The ARMI member also recently won the $100K Lilly x Nucleate Grand Challenge. #ARMIMember #AIS26 #Biomanufacturing #NextGenBioMed #NextGenBioTech

Cellbricks was named an #AIS26 runner-up for its biofabrication platform designed to produce human tissue therapeutics at scale. The ARMI member is currently seeking investors for its $20M Series A round. #Biomanufacturing #NextGenBioMed #NextGenBioTech #ARMIMember @cllbrcks

#GyroGel received the 2026 Breakthrough Technology Award at #AIS26 for its patient-specific, 3D-printed bone graft designed to restore jawbone without autografting. The award includes automatic enrollment in BioFab Startup Lab Cohort 5.

Building, funding, or commercializing next-gen biotherapeutics or biomanufacturing tech? Join founders, investors & innovators. Ten companies pitch what’s next. ow.ly/ombX50ZXNiP #AIS26 | October 20 | Manchester, NH #ReGenValley #Biomanufacturing #NextGenBiotherapeutics

Member Aspen Neuroscience is advancing personalized cell therapies for Parkinson’s disease. Its lead candidate, ANPD001, has FDA Fast Track designation, and the company recently filed for a proposed IPO. Read more: ow.ly/mX3L50ZXI1F. #celltherapy #Parkinsons #ReGenMed

At the 2026 ARMI Investment Summit Pitch Competition, founders present their technologies and commercialization strategies to investors and industry leaders. Join Us Oct. 20 | Manchester, NH armiusa.org/event/biofab-inv… #biomanufacturing #nextgenbiomed #nextgenbiotherapeutics #AIS26

TURN INNOVATION INTO MOMENTUM Applications are open for Cohort 5 of the BioFab Startup Lab. Gain the expertise, mentorship and connections to move your biotechnology toward commercialization. Apply by October 9: ow.ly/VWw250ZQNFv #BioFabStartupLab #BiotechStartups

Heading to #CGMESA26? Connect with ARMI | BioFabUSA in Phoenix, Oct. 5–7. Learn about Richard McFarland’s Innovation Spotlight, ask about our Oct. 6 mixer, or arrange a time to meet: [email protected] #Biomanufacturing #NextGenCellTherapies #NextGenBiotherapeutics

What does decentralized manufacturing mean for the future of cell therapy? ARMI | BioFabUSA’s Richard McFarland, MD, PhD, brings a regulatory and manufacturing perspective to that conversation at Cell & Gene Therapy International, Sept. 22–25 in Boston. ARMI members save 30%.

High-quality companies. Meaningful discussions. Amazing community. Join founders, investors, industry partners, manufacturers, commercialization professionals and innovation leaders at #AIS26. Oct. 20 | Manchester, NH armiusa.org/event/biofab-inv… #NextGenBioMed #NextGenCellTherapies

The right room can change what happens next. Save your spot! Join founders, investors, manufacturers and commercialization leaders at the 2026 ARMI Investment Summit. Oct. 20 | Manchester, NH Register: ow.ly/nRk950ZLzmb #AIS26 #NextGenBioMed

What does decentralized manufacturing mean for the future of cell therapy? ARMI | BioFabUSA’s Richard McFarland, MD, PhD, brings a regulatory and manufacturing perspective to that conversation at Cell & Gene Therapy International, Sept. 22–25 in Boston. ARMI members save 30%.

Burlington, MA-based @AzentaSciences worked with ARMI | BioFabUSA to compare automated vs. manual cryogenic storage. Results showed faster, safer sample retrieval without sacrificing iPSC quality. Read more: ow.ly/XmJN50ZItJ1 #NextGenBioMed #NextGenBioTech #cryopreservation

THE SPOTLIGHT IS WAITING, THE CLOCK IS NOT. It is the FINAL DAY to apply for the BioFab Startup Lab Pitch Competition at the 2026 ARMI Investment Summit. Applications close TONIGHT at 11:59 p.m. EDT. surveymonkey.com/r/2026BFISP… #Biomanufacturing #NextGenBioMed #NextGenBioTech #AIS26

THE FUTURE OF NEXT-GENERATION BIOTHERAPEUTICS WILL NOT BUILD ITSELF. Scale. De-risk. Take the stage at #AIS26. Your future self will thank you. Your present self has until 11:59 p.m. EDT tomorrow. Apply: surveymonkey.com/r/2026BFISP… #NextGenBioMed #BioFabStartuplab #Biomanufacturing

What can five minutes at the ARMI Investment Summit unlock? Scale your innovation, de-risk the path forward and speed progress toward commercialization. Pitch to investors and industry experts. Apply by Aug. 28: surveymonkey.com/r/2026BFISP… #AIS26 #NextGenBioMed #NextGenCellTherapy

#ARMIInvestmentSummit Pitch applications close this Friday 8/28! Take the stage at #AIS26 and compete for the Breakthrough Technology Award. THE DOOR IS STILL OPEN. STEP THROUGH IT. Apply: surveymonkey.com/r/2026BFISP… #BioFabStartupLab #NextGenBioMed #NextGenCellTherapy #Startuplab

ARE YOU READY TO PITCH? Compete for the 2026 Breakthrough Technology Award at the ARMI Investment Summit 10/20 Manchester, NH. Accelerating Commercialization. Connecting Capital. Building the Bioindustrial Future. Applications close 8/21 ow.ly/yXx450ZyLzB #NextGenBio

Member Spotlight: @hepatx is advancing allogeneic cell-based therapies for liver disease. Recent milestones in preclinical validation and scalable therapeutic cell preservation and transport mark continued progress toward commercialization. #NextGenBioMed #NextGenBioTech

Have a breakthrough technology ready for commercialization? Apply to pitch at the 2026 ARMI Investment Summit and present to investors and industry leaders. Applications close Aug. 21. ow.ly/U0Gz50ZwmSu #Biomanufacturing #NextGenBioMed #NextGenBioTech